Your English writing platform
Discover LudwigSuggestions(1)
Exact(1)
I would never want to withdraw clinical observation but I would want to do RCA's in all future ECTVs.
Similar(59)
The influence of family responsibilities on the decision to withdraw from clinical practice was particularly felt by female physicians in our study, as found by others [ 8].
Both have demonstrated efficacy in preclinical models of bone loss, with Denosumab progressing through clinical trials; Fc-OPG was withdrawn from clinical trials due to immune side effects.
Balicatib inhibits cathepsin K and showed potential to inhibit osteolysis and regain bone mass, but it was withdrawn from clinical trials due to safety issues [73]; Odanacatib, another cathepsin K inhibitor, was also withdrawn from clinical trials for breast cancer bone metastasis for safety concerns [11], [74].
Ionescu-Shiley valve was withdrawn from clinical use in 1987 for its early structural failure after implantation.
The protocol included an arm for chlorproguanil/dapsone in the 6 59 month study after the SP arm was completed, however it was not possible to procure the drug and recently the drug has been withdrawn from clinical development[26].
Medication was withdrawn for clinical, not research reasons.
However, both compounds have been withdrawn from clinical use due to off-target effects (3, 4).
AspB10 was withdrawn from clinical development due to a higher incidence of breast cancer in rats after 12 months [ 3].
In terms of side-effects, as discussed in detail below, there are few side-effects associated with teriparatide treatment and subjects rarely withdrew from clinical trials.
Troglitazone, which was the first agent in this class to receive labeling approval, was withdrawn from clinical use in the US due to hepatotoxicity [ 30].
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com